Antigenic structure analysis of VP3 of infectious bursal disease virus

Virus Research

Volumn 129, Issue 1, 2007, Pages 35-42

  Deng, Xiaoyun ^a   Gao, Yulong ^a   Gao, Honglei ^a   Qi, Xiaole ^a   Cheng, Yu ^a   Wang, Xiaoyan ^a   Wang, Xiaomei ^a  

^a Harbin Veterinary Research Institute   (China)

Author keywords

Epitope; Infectious bursal disease virus (IBDV); Pepscan; VP3

Indexed keywords

EPITOPE; MONOCLONAL ANTIBODY; PROTEIN VP3; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGENIC VARIATION; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; FIBROBLAST; IMMUNIZATION; IMMUNOGENICITY; INFECTION; INFECTIOUS BURSAL DISEASE VIRUS; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; SCREENING; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; ANTIGENS, VIRAL; BIRNAVIRIDAE INFECTIONS; CELLS, CULTURED; CHICK EMBRYO; CHICKENS; EPITOPE MAPPING; EPITOPES, B-LYMPHOCYTE; FEMALE; IMMUNE SERA; IMMUNIZATION; INFECTIOUS BURSAL DISEASE VIRUS; MICE; MICE, INBRED BALB C; POULTRY DISEASES; RECOMBINANT PROTEINS; VIRAL STRUCTURAL PROTEINS;

ESCHERICHIA COLI; INFECTIOUS BURSAL DISEASE VIRUS; MUS;

EID: 34548244553     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2007.05.003     Document Type: Article

References (33)

1. Azad A.A., Barret S.A., and Fahey K.J. The characterization and molecular cloning of the double-stranded dsRNA genome of an Australian strain of infectious bursal disease virus. Virology 143 (1985) 35-44
2. Azad A.A., Jagadish M.N., Brown M.A., and Hudson P.J. Deletion mapping and expression in Escherichia coli of the large genomic segment of a Birnavirus. Virology 161 (1987) 145-152
3. Binder M., Vogtle F.N., Michelfelder S., Muller F., Illerhaus G., Sundararajan S., Mertelsmann R., and Trepel M. Identification of their epitope reveals the structural basis for the mechanism of action of the immunosuppressive antibodies basiliximab and daclizumab. Cancer Res. 67 8 (2007) 3518-3523
4. Coulibaly F., Chevalier C., Gutsche I., Pous J., Navaza J., Bressanelli S., Delmas B., and Rey F.A. The Birnavirus crystal structure reveals structural relationships among icosahedral viruses. Cell 120 (2005) 761-772
5. Christophe C., Jean L., Bruno D.C., and Bernard D. The last C-terminal residue of VP3, glutamic acid 257, controls capsid assembly of infectious bursal disease virus. J. Virol. 78 (2004) 3296-3303
6. Cui X.L., Nagesha H.S., and Holmes I.H. Mapping of conformational epitopes on capsid protein VP2 of infectious bursal disease virus by fd-tet phage display. J. Virol. Methods 114 1 (2003) 109-112
7. Dobos P., Hill B.J., Hallett R., Kells D.T., Becht H., and Teninges D. Biophysical and biochemical characterization of five animal viruses with bisegmented double-stranded RNA genomes. J. Virol. 32 (1979) 593-605
8. Fahey K.J., O'Donnell I.J., and Bagust T.J. Antibody to the 32 K structural protein of infectious bursal disease virus neutralizes viral infectivity in vitro and confers protection on young chickens. J. Gen. Virol. 66 (1985) 2693-2702
9. Garriga D., Querol-Aud J., Abaitua F., Saugar, Pous J., Verdaguer N., Caston J., and Rodriguez G. The 2.6-angstrom structure of infectious bursal disease virus-derived T = 1 particles reveals new stabilizing elements of the virus capsid. J. Virol. 80 (2006) 6895-6905
10. Heine H.G., Haritou M., Failla P., Fahey K., and Azad A.A. Sequence analysis and expression of the host-protective immunogen VP2 of a variant strain of infectious bursal disease virus which can circumvent vaccination with standard type 1 strains. J. Gen. Virol. 72 (1991) 1835-1843
11. Hjalmarsson A., Carlemalm E., and Everitt E. Infectious pancreatic necrosis virus: identification of a VP3-containing ribonucleoprotein core structure and evidence for O-linked glycosylation of the capsid protein VP2. J. Virol. 73 (1999) 3484-3490
12. Hjalmarsson A., and Everitt E. Identification of IPNV-specified components released from productively infected RTG-2 cells following massive cytopathic effect. Arch. Virol. 144 (1999) 1487-1501
13. Hudson P.J., McKem N.M., Power B.E., and Azad A.A. Genomic structure of the large RNA segment of infectious bursal disease virus. Nucleic Acid Res. 14 (1986) 5001-5002
14. Jagadish M.N., and Azad A.A. Localization of a VP3 epitope of infectious bursal disease virus. Virology 184 (1991) 805-807
15. Kibenge F.S.B., Qian B., Cleghorn J.R., and Martin C.K. Infectious bursal disease virus polyprotein processing does not involve cellular proteases. Arch. Virol. 142 (1997) 2401-2419
16. Lee C.C., Ko T.P., Chou C.C., Yoshimura M., Doong S.R., Wang M.Y., and Wang A. Crystal structure of infectious bursal disease virus VP2 subviral particle at 2.6 Å resolution: implications in virion assembly and immunogenicity. J. Struct. Biol. 155 1 (2006) 74-86
17. Lombardo E., Maraver A., Espinosa I., Fernández-Arias A., and Rodríguez J.F. VP5, the nonstructural polypeptide of infectious bursal disease virus, accumulates within the host plasma membrane and induces cell lysis. Virology 277 (2000) 345-357
18. Luque, D., Saugar, I., Rodriguez, J.F., Verdaguer, N., Garriga, D., Martin, C.S., Velazquez-Muriel, J.A., Trus, B.L., Carrascosa, J.L., Caston, J.R., 2007. Infectious bursal disease virus capsid assembly and maturation by structural rearrangements of a transient molecular switch. J. Virol., in press.
19. Mahardika G.N.K., and Becht H. Mapping of cross-reacting and serotype-specific epitopes on the VP3 structural protein of the infectious bursal disease virus (IBDV). Arch. Virol. 140 (1995) 765-774
20. McFerran J.B., McNulty M.S., McKillop E.R., Conner T.J., McCracken R.M., Collins D.S., and Allan G.M. Isolation and serological studies with infectious bursal disease viruses from fowl, turkeys and ducks: demonstration of a second serotype. Avian Pathol. 9 (1980) 395-404
21. Tacken M.G.J., Van Den Beuken P.A.J., and Peeters B.P.H. Homotypic interactions of the infectious bursal disease virus proteins VP3, pVP2, VP4, and VP5: mapping of the interacting domains. J. Virol. 312 2003 (2003) 306-319
22. Muller H., and Nitschke R. The two segments of the infectious bursal disease virus genome are circularized by a 90,000-Da protein. Virology 159 (1987) 174-177
23. Mundt E., Beyer J., and Muller H. Identification of a novel viral protein in infectious bursa disease virus-infected cells. J. Gen. Virol. 76 (1995) 437-443
24. Mundt E., Kollner B., and Kretzschmar D. VP5 of infectious bursal disease virus is not essential for viral replication in cell culture. J. Virol. 71 (1997) 5647-5651
25. Oppling V., Muller H., and Brecht H. The structural polypeptide VP3 of infectious bursal disease virus carries group- and serotype-specific epitopes. J. Gen. Virol. 72 (1991) 2275-2278
26. Pitcovski J., Levi B.Z., Maray T., Di-Castro D., Safadi A., Krispel S., Azriel A., Gutter B., and Michael A. Failure of viral protein 3 of infectious bursal disease virus produced in prokaryotic and eukaryotic expression systems to protect chickens against the disease. Avian Dis. 43 (1999) 8-15
27. von Einem U.I., Gorbalenya A.E., Schirrmeier H., Behrens S., Letzel T., and Mundt E. VP1 of infectious bursal disease virus is an RNA-dependent RNA polymerase. J. Gen. Virol. 85 (2004) 2221-2229
28. Wang X.M., Fu C.Y., Gao H.L., Song X.L., Zeng X.W., Zhang M.F., and Wallace B.L. Pathogenic antigenic and molecular characterization of the very virulent strains (Gx) of infectious bursal disease virus isolated in China. Agric. Sci. China 5 (2003) 566-572
29. Wang X.N., Zhang G.P., Zhou J.Y., Feng C.H., Yang Y.Y., Li Q.M., Guo J.Q., and Qiao H.X. Identification of neutralizing epitopes on the VP2 protein of infectious bursal disease virus by phage-displayed heptapeptide library screening and synthetic peptide mapping. Viral Immunol. 18 (2005) 549-557
30. Yamaguchi T., Iwata K., Kobayashi M., Ogawa M., Fukushi H., and Hirai K. Epitope mapping of capsid proteins VP2 and VP3 of infectious bursal disease virus. Arch. Virol. 141 (1996) 1493-1507
31. Yao K., Goodwin M.A., and Vakharia V.N. Generation of a mutant infectious bursal disease virus that does not cause bursal lesions. J. Virol. 72 (1998) 2647-2654
32. In: Zhang G.S., and Rong B.P. (Eds). Application of Monoclonal Antibody in Medicine (1987), Shanghai Science and Technology Publishing House, Shanghai 299-300
33. Zhou Y.J., An T.Q., He Y.X., Liu J.X., Qiu H.J., Wang Y.F., and Tong G.Z. Antigenic structure analysis of glycosylated protein 3 of porcine reproductive and respiratory syndrome virus. Virus Res. 118 1-2 (2006) 98-104